Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Vito Trinchieri"'
Autor:
Salvatore Venosi, Giancarlo Ceccarelli, Massimiliano de Angelis, Luca Laghi, Laura Bianchi, Ombretta Martinelli, Debora Maruca, Eugenio Nelson Cavallari, Fabrizia Toscanella, Paolo Vassalini, Vito Trinchieri, Alessandra Oliva, Gabriella d’Ettorre
Publikováno v:
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-9 (2019)
Abstract Background A wide debate is ongoing regarding the role of cutaneous dysbiosis in the pathogenesis and evolution of difficult-to-treat chronic wounds. Nowadays, probiotic treatment considered as an useful tool to counteract dysbiosis but the
Externí odkaz:
https://doaj.org/article/c36c6a745168488bafcd1fd14ba8d17e
Autor:
Vito Trinchieri, Massimiliano Marazzato, Giancarlo Ceccarelli, Francesca Lombardi, Alessandra Piccirilli, Letizia Santinelli, Luca Maddaloni, Paolo Vassalini, Claudio Maria Mastroianni, Gabriella d’Ettorre
Publikováno v:
Biomedicines, Vol 10, Iss 8, p 1851 (2022)
Background: Although useful in the time-race against COVID-19, CPAP cannot provide oxygen over the physiological limits imposed by severe pulmonary impairments. In previous studies, we reported that the administration of the SLAB51 probiotics reduced
Externí odkaz:
https://doaj.org/article/89ca0e830cfe463a8320ab239a169268
Autor:
Gabriella d'Ettorre, Giancarlo Ceccarelli, Massimiliano Marazzato, Giuseppe Campagna, Claudia Pinacchio, Francesco Alessandri, Franco Ruberto, Giacomo Rossi, Luigi Celani, Carolina Scagnolari, Cristina Mastropietro, Vito Trinchieri, Gregorio Egidio Recchia, Vera Mauro, Guido Antonelli, Francesco Pugliese, Claudio Maria Mastroianni
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Background: Gastrointestinal disorders are frequent in COVID-19 and SARS-CoV-2 has been hypothesized to impact on host microbial flora and gut inflammation, infecting intestinal epithelial cells. Since there are currently no coded therapies or guidel
Externí odkaz:
https://doaj.org/article/6f96a33e3f5d49afbc1352da0914cdfd
Autor:
Giancarlo Ceccarelli, Massimiliano Marazzato, Luigi Celani, Francesca Lombardi, Alessandra Piccirilli, Massimo Mancone, Vito Trinchieri, Francesco Pugliese, Claudio M. Mastroianni, Gabriella d’Ettorre
Publikováno v:
Nutrients, Vol 13, Iss 8, p 2898 (2021)
Background: We previously reported that severe COVID-19 patients had higher chances of survival and a reduced risk of developing respiratory failure when administered with the probiotic formulation SLAB51. This study aimed to investigate further bact
Externí odkaz:
https://doaj.org/article/bfb78fbfe526474188742ebb3717baa4
Autor:
Vito Trinchieri, Luca Laghi, Beatrice Vitali, Carola Parolin, Ilaria Giusti, Daniela Capobianco, Paola Mastromarino, Claudio De Simone
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
BackgroundVariability in probiotics manufacturing may affect their properties, with potential implications for their efficacy and safety. This is of particular concern with probiotic products destined for use in patients with serious medical conditio
Externí odkaz:
https://doaj.org/article/30f55337dc454d20a55a663bda09eb34
Autor:
Giuseppe Famularo, Sonia Tzantzoglou, Gino Santini, Vito Trinchieri, Sonia Moretti, Aleardo Koverech, Claudio De Simone
Publikováno v:
Mediators of Inflammation, Vol 2, Iss 7, Pp S29-S32 (1993)
The authors demonstrated that in vivo administered L-carnitine strongly ameliorated the immune response in both healthy individuals receiving Intralipid and ageing subjects with cardiovascular diseases, as shown by the enhancement of mixed lymphocyte
Externí odkaz:
https://doaj.org/article/1b9651593f674ad88cbbd4b95dd83389
Autor:
Gabriella d'Ettorre, Alessandra Piccirilli, Claudio Maria Mastroianni, Francesca Lombardi, Massimo Mancone, Francesco Pugliese, Giancarlo Ceccarelli, Vito Trinchieri, Massimiliano Marazzato, Luigi Celani
Publikováno v:
Nutrients
Volume 13
Issue 8
Nutrients, Vol 13, Iss 2898, p 2898 (2021)
Volume 13
Issue 8
Nutrients, Vol 13, Iss 2898, p 2898 (2021)
Background: We previously reported that severe COVID-19 patients had higher chances of survival and a reduced risk of developing respiratory failure when administered with the probiotic formulation SLAB51. This study aimed to investigate further bact
Autor:
Gianfranco Fanello, Gabriella d'Ettorre, Noemi Giustini, Sara Serafino, Giacomo Rossi, Ivan Schietroma, Vito Trinchieri, Saeid Najafi Fard, Fausto Fiocca, Jason M. Brenchley, Silvia Scarpona, Paola Mastromarino, Guido Antonelli, Carla Selvaggi, Carolina Scagnolari, Giuseppe Corano Scheri, Mauro Andreotti, Vincenzo Vullo, Giancarlo Ceccarelli
Publikováno v:
Immunity, Inflammation and Disease. 5:244-260
Introduction HIV infection is characterized by a persistent immune activation associated to a compromised gut barrier immunity and alterations in the profile of the fecal flora linked with the progression of inflammatory symptoms. The effects of high
Autor:
Laura Bianchi, Debora Maruca, Vito Trinchieri, Eugenio Nelson Cavallari, Massimiliano De Angelis, Paolo Vassalini, Fabrizia Toscanella, S. Venosi, Ombretta Martinelli, Gabriella d'Ettorre, Alessandra Oliva, Giancarlo Ceccarelli, Luca Laghi
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-9 (2019)
Journal of Translational Medicine, Vol 17, Iss 1, Pp 1-9 (2019)
Background A wide debate is ongoing regarding the role of cutaneous dysbiosis in the pathogenesis and evolution of difficult-to-treat chronic wounds. Nowadays, probiotic treatment considered as an useful tool to counteract dysbiosis but the evidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::087ab7a5853021ee7ef131ce656b2fe3
https://hdl.handle.net/11365/1225594
https://hdl.handle.net/11365/1225594
Autor:
Alessia Cipolla, Claudio Maria Mastroianni, Francesca Tierno, Gianluca Russo, Claudia D'Agostino, Francesca Gizzi, Marco Iannetta, Alessandra Oliva, Vito Trinchieri, Alessandra D'Abramo, Maria Teresa Mascellino, Vincenzo Vullo
Publikováno v:
Clinical Microbiology and Infection. 22:147-153
Available therapeutic options against carbapenem-resistant Klebsiella pneumoniae (CR-Kp) are limited because of the high level of resistance to other antimicrobial classes including polymyxins. The double-carbapenem regimen has been recently consider